ZRZuzanna Rabczak

Zuzanna Rabczak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zuzanna Rabczak has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    THE INFLUENCE OF HAND DOMINANCE ON THE EFFECTIVENESS OF ORAL HYGIENE - LITERATURE REVIEW

    by Zuzanna Rabczak, Karolina Piatikow, Jakub Rusek, Patrycja PęKala, Gabriela Opolska, Jakub Sobstyl, Piotr PęKala, Julia Marek, Zuzanna Skowronek, Katarzyna Rusek

    Introduction: The Human Microbiome Project (HMP) has advanced our understanding of the microbiome's role in health and disease. The oral cavity hosts a complex microbiome, comprising over 750 microbial species, including bacteria, archaea, viruses, and fungi. Bacteria, forming dental plaque biofilm, are the primary cause of caries and periodontal diseases. Factors such as oral hygiene and diet influence oral health, with handedness potentially affecting plaque removal efficiency. Methodology: This review, sourced from PubMed, Scopus, and Google Scholar, analyzes hand lateralization’s impact on dental plaque removal and neuroplastic changes linked to motor skill acquisition, using fMRI and mirror neuron studies. Keywords: oral hygiene, handedness, dental plaque, motor skills, oral microbiome. Discussion: Handedness subtly influences dental plaque removal, with right-handers showing better upper left quadrant cleaning and left-handers favoring right quadrants. However, standardized training minimizes these differences, emphasizing technique and education over hand dominance. Conclusions: Handedness has a minor impact on dental plaque removal, with quadrant-specific differences due to accessibility and brushing dynamics. Proper instruction reduces these disparities, emphasizing technique, dexterity, and motivation. Neural plasticity supports non-dominant hand improvement. Future research should explore motor learning and behavioral factors to optimize oral hygiene.

  • Open Access

    EFFICACY AND SAFETY OF IL-23 INHIBITORS IN PSORIATIC ARTHRITIS: A LITERATURE REVIEW

    by Julia Marek, Aleksandra Wiśniewska, Karolina Kasprzak, Małgorzata Kuczek, Zuzanna Rabczak, Justyna Tasior

    Introduction: Psoriatic arthritis (PsA) is a chronic, heterogeneous immune-mediated inflammatory disease affecting multiple clinical domains, including peripheral arthritis, skin lesions, enthesitis, and dactylitis. Given the key role of the IL-23/IL-17 axis in PsA pathogenesis, IL-23 inhibitors have emerged as an important therapeutic option. Methodology: A structured literature search of the PubMed database was performed to identify studies evaluating the efficacy and safety of IL-23 inhibitors in PsA. The available evidence was based mainly on randomized trials of guselkumab, risankizumab, and tildrakizumab. Phase III randomized controlled trials were prioritized, while relevant meta-analyses, network meta-analyses, systematic reviews, and selected post hoc or pooled analyses were included to complement the assessment of multidomain outcomes, structural progression, and safety. Results: IL-23 inhibitors showed significant efficacy in peripheral arthritis and provided clinically meaningful benefits in other important disease domains, including skin lesions, physical function, minimal disease activity, enthesitis, and dactylitis. The most robust evidence supported guselkumab and risankizumab, whereas the evidence base for tildrakizumab remained more limited. Guselkumab also showed the clearest evidence for inhibition of structural progression. Across studies, IL-23 inhibitors demonstrated a generally favorable and stable safety profile, with infections being the most commonly reported adverse events and no clear emerging long-term safety concerns. Conclusions: IL-23 inhibitors represent an effective and clinically relevant therapeutic strategy in PsA, with benefits across multiple disease domains and a generally favorable safety profile. Current evidence most strongly supports guselkumab and risankizumab, while further data are needed to better define the role of tildrakizumab.

  • Open Access

    TOPICAL EFLORNITHINE TREATMENT FOR HIRSUTISM IN WOMEN: SUMMARY OF FINDINGS

    by Aleksandra Wiśniewska, Małgorzata Kuczek, Karolina Kasprzak, Zuzanna Rabczak, Julia Marek, Justyna Tasior

    Introduction: Hirsutism impacts 5–10% of women of reproductive age, characterized by excessive male-pattern terminal hair growth. Excess facial hair is notably distressing given its visibility, commonly diminishing women's perceptions of femininity. Evidence from clinical studies reveals that eflornithine attenuates facial hair proliferation and conspicuousness, thereby ameliorating quality of life. Aim of the study: This study aims to provide a comprehensive analysis of the scientific evidence on the effectiveness of topical eflornithine preparations in the treatment of hirsutism in women. The analysis focused specifically on monotherapy with eflornithine or in combination with other therapies such as laser and intense pulsed light treatments. Pharmacokinetics and safety of use were also evaluated. The data collected were synthesized descriptively to support a comparative assessment of different eflornithine-based treatment strategies. Material and method: This study used a systematic literature review methodology to synthesize the scientific evidence on the efficacy of topical eflornithine in the treatment of hirsutism in women. The literature review was compiled using the PubMed and Google Scholar platforms, including articles published between 2001 and 2006. Results: Topical eflornithine emerges as an efficacious intervention for hirsutism in women, demonstrating superior clinical outcomes whether employed as monotherapy or adjunctively with laser or IPL therapies.

  • Open Access

    GASTRIC BEZOAR AND SUBSEQUENT BLEEDING IN A 73-YEAR OLD WOMAN – CASE REPORT

    by Michał Szalach, Mateusz Jasiński, Zuzanna Rabczak, Marcin Narloch, Kamila Mozga, Małgorzata Kuczek, Jakub Rusek, Justyna Tasior, Bartosz Burda, Justyna Wyroślak-Najs

    Bezoar is a mass of swallowed foreign material most often composed of hair or fiber. Commonly, bezoars occur in young women with a history of psychiatric disorders, especially trichotillomania and trichophagia. Diagnostically, gastroscopy remains the gold standard. Prevalence is low, affecting up to 0.4% of the general population. Bezoars can lead to ulcer formation and hemorrhagic complications. Literature describes various treatment options, including endoscopic, laparoscopic and open surgical approaches. Psychiatric consultation and follow up are crucial for recurrence prevention. A 73-year old woman with a history of gastric ulcers and depression was urgently admitted to general surgery ward due to fatigue, abdominal pain and a suspicion of gastrointestinal hemorrhage. Outpatient gastroscopy revealed extensive ulceration of the posterior wall of the stomach, a large bezoar and pyloric stenosis. On admission, patient was severely anemic. Endoscopic haemostasis proved unfeasible due to the large bezoar. After initial stabilization, operative treatment was recommended. Laparotomy was performed revealing thickening on the posterior wall of the stomach, stenosis of the duodenum and a large diverticulum on the anterior wall of the descending part of the duodenum. Subtotal gastrectomy and diverticulum resection was performed. Restoration of gastrointestinal continuity was carried out using the Roux-en-Y method. Examination of the specimen confirmed the presence of a four centimeter bezoar and a three centimeter gastric ulcer. Post-surgery period was complicated by pneumonia and peripheral pulmonary embolism. Patient was discharged after treatment in good general and local condition after fifteen days since admission. Despite being rare, bezoars occur and should be taken into consideration during differential diagnosis of gastric symptoms and dyspepsia, even in the elderly population, especially with a history of psychiatric disorders. Bezoars can prevent endoscopic treatment of gastric hemorrhage and force surgeons to perform extensive surgical resections.

  • Open Access

    PAIN MANAGEMENT IN THE EMERGENCY DEPARTMENT - A LITERATURE REVIEW

    by Michał Szalach, Aleksandra Żywicka, Zuzanna Rabczak, Marcin Narloch, Kamila Mozga, Mateusz Jasiński, Małgorzata Kuczek, Jakub Rusek, Justyna Tasior, Bartosz Burda

    Introduction: Pain is the most common presenting symptom in emergency departments and requires timely, accurate assessment and effective management to prevent complications and improve patient outcomes. This review focuses on the mechanisms, classification, and management strategies for acute pain in the ED, including common clinical presentations and evidence-based therapeutic approaches. Materials and methods: A literature search was conducted in the PubMed database to find recent systematic reviews and meta-analyses on pain management in emergency medicine. Keywords included: pain, analgesics, emergency department, injury. Results: A review of the literature indicates that pain management in emergency medicine is primarily guided by the type, cause, and severity of pain. A multimodal approach offers significant therapeutic benefits. Despite local differences in drug preferences and clinical guidelines, accurate pain assessment and the prompt, appropriate adjustment of analgesics to symptom intensity remain a fundamental principle of pain management. Equally important is the use of adjuvant therapies and non-pharmacological interventions, including psychological support, individualized care and effective communication with the patient. Conclusion: Effective pain management in emergency settings requires a structured, patient-centered, and interdisciplinary approach. Incorporating both pharmacologic and supportive strategies not only enhances acute symptom relief but also contributes to better long-term outcomes and healthcare resource utilization.

  • Open Access

    HOW TO EFFECTIVELY PROTECT THE HUMAN BODY FROM THE HARMFUL INFLUENCE OF XENOESTROGENS AND OTHER ENDOCRINE DISRUPTORS: PREVENTIVE AND THERAPEUTIC PERSPECTIVES

    by Małgorzata Kuczek, Aleksandra Wiśniewska, Karolina Kasprzak, Zuzanna Rabczak, Julia Marek, Justyna Tasior, Mateusz Jasiński, Michał Szalach, Aleksandra Żywicka, Natalia Kaleta

    Xenoestrogens constitute a group of endocrine-disrupting chemicals that, by mimicking or interfering with the actions of endogenous estrogens, can affect hormonal balance and reproductive function. Due to their widespread presence in the environment—including plastics, cosmetics, food, and everyday consumer products—complete avoidance of exposure is virtually impossible. However, studies indicate that proper education, lifestyle modifications, and dietary interventions can significantly reduce exposure to these compounds and the associated health risks. This article investigates various strategies for the prevention of xenoestrogen and other endocrine disruptors exposure, the reduction of existing body burdens of these chemicals. The effectiveness of dietary and behavioral interventions is discussed, such as avoiding canned foods and plastic products, as well as using personal care products free from phthalates, parabens, triclosan, and benzophenone-3, all of which have been shown to markedly decrease urinary levels of xenoestrogens and other endocrine disruptors. Therapeutic interventions are also presented, including the use of selected supplements and pharmacological agents such as Chlorella pyrenoidosa, cholestyramine, olestra, coenzyme Q10, melatonin, and multi-strain probiotics, which have demonstrated beneficial effects in reducing the concentrations of endocrine-active compounds and mitigating their toxic effects. These findings underscore the critical role of multifaceted approaches, combining preventative behavioral changes with targeted substance interventions, to effectively mitigate exposure and safeguard public health from ubiquitous endocrine-disrupting chemicals (EDCs).

  • Open Access

    IS THERE A PATH TO LASTING RELIEF? A REVIEW OF PHARMACOLOGICAL TREATMENT FOR VULVODYNIA

    by Karolina Kasprzak, Małgorzata Kuczek, Aleksandra Wiśniewska, Stanisław Kasprzak, Zuzanna Rabczak, Julia Marek, Justyna Tasior

    Introduction: Vulvodynia is defined as discomfort of the vulva that lasts for at least three months and is clinically considered an idiopathic pain syndrome, presenting both diagnostic and therapeutic challenges.While non-pharmacological interventions such as pelvic floor physical therapy and psychotherapy provide relief for some patients, many require pharmacological treatment for persistent discomfort. Despite the availability of various pharmaceutical options, standardized treatment protocols are lacking, and comparative efficacy data remain limited. This review examines current pharmacological approaches for vulvodynia and assesses their effectiveness in managing symptoms. Results: Following a rigorous selection process, 29 articles met the inclusion criteria. The available evidence supports the efficacy of oral medications, particularly amitriptyline as a first-line treatment, and topical lidocaine in managing vulvodynia. Furthermore, the integration of physiotherapy alongside pharmacological management appears to enhance patient outcomes. Botulinum toxin injections did not yield statistically significant improvement in the studies included in the review. Conclusions: Amitriptyline and topical lidocaine have demonstrated efficacy for vulvodynia, particularly when combined with physiotherapy. Future research should focus on investigating the long-term efficacy of combined therapies and exploring the underlying mechanisms of vulvodynia to develop targeted treatments.

  • Open Access

    LONG-TERM EFFECTS OF DENTAL IMPLANTS IN PATIENTS WITH OSTEOPOROSIS - A LITERATURE REVIEW

    by Zuzanna Rabczak, Karolina Kasprzak, Małgorzata Kuczek, Aleksandra Wiśniewska, Julia Marek, Mateusz Jasiński, Michał Szalach, Marcin Narloch

    Introduction: Osteoporosis, a common metabolic bone disease affecting over 200 million people globally, causes decreased bone mass and structural deterioration, increasing fracture risk and reducing quality of life. Dental implants have become a standard treatment for tooth loss, providing functional and aesthetic restoration. However, in osteoporotic patients, compromised bone quality may challenge osseointegration and long-term implant stability, requiring careful assessment and individualized planning. Methodology: A literature review of PubMed, Scopus, and Google Scholar identified recent systematic reviews and meta-analyses on dental implant outcomes in osteoporotic patients, focusing on implant survival, bone loss, and antiresorptive therapy, with studies ≥1-year follow-up included. Results: Most studies show no significant difference in implant survival between osteoporotic and healthy patients, with rates typically above 90%. Slight but significant marginal bone loss was noted, though clinically minor. Bone density and osseointegration were generally comparable, particularly with individualized care and antiresorptive therapy. Osteonecrosis of the jaw was rare and mainly associated with bisphosphonate use. Age, systemic treatment, and local bone conditions influenced outcomes. Factors including patient age, systemic therapy, and local bone conditions influenced implant outcomes. Conclusion: Dental implants in osteoporotic patients demonstrate high survival and predictable outcomes. Minor bone loss is manageable with monitoring and preventive care. Although antiresorptive therapy may increase osteonecrosis risk, interdisciplinary management minimizes complications. Osteoporosis should not be viewed as a contraindication for implant therapy, though further research is needed to refine treatment protocols.

  • Open Access

    OBESITY DISEASE - NON-SURGICAL TREATMENT METHODS - A LITERATURE REVIEW

    by Zuzanna Rabczak, Marcin Narloch, Jakub Kamiński, Jan Tomczyk, Aleksandra Żywicka, Oskar Sienkiel, Kamila Mozga, Mateusz Jasiński, Michał Szalach, Stanisław Kasprzak

    Introduction: Obesity, a global health crisis, is a leading risk factor for chronic diseases like diabetes and cardiovascular disease. Its prevalence has more than doubled since 1990, straining healthcare systems. Management involves primary prevention (lifestyle interventions), secondary prevention (early detection and treatment), and tertiary prevention (managing established obesity via lifestyle changes, pharmacotherapy, or bariatric surgery). This review focuses on non-invasive treatment methods for obesity. Materials and methods: This review was conducted using PubMed and Google Scholar databases, focusing on recent systematic reviews, meta-analyses, and original research on non-surgical obesity treatments. Keywords included obesity, diet, exercise, pharmacotherapy, and education. Results: Recent findings suggest that combining reduced calorie intake with limited carbohydrate consumption can lead to more effective weight loss. Diets high in protein, particularly those containing whey, are beneficial for maintaining muscle mass during weight reduction. Medications such as GLP-1 receptor agonists support weight loss and metabolic health. Regular physical activity enhances fat loss and cardiovascular performance. Additionally, patient-focused strategies are essential for improving adherence and ensuring long-term success in obesity treatment. Conclusions: Effective obesity treatment requires combining personalized nutrition plan, physical activity, and medications. Prioritizing muscle preservation, protein intake, patient education, and stigma reduction enhances adherence and supports long-term weight and metabolic health outcomes.

  • Open Access

    DIFFERENTIAL DIAGNOSIS OF ACUTE DIFFUSE ENCEPHALOMYELITIS (ADEM) AND MULTIPLE SCLEROSIS (MS) - CASE REPORT

    by Marcin Narloch, Marcelina Kurek, Weronika Skrzypek, Szymon Skrzypek, Natalia Domańska, Wiktoria Garbacz, Anna Gryc, Zuzanna Rabczak

    Acute Disseminated Encephalomyelitis (ADEM) is an acute, immune-mediated demyelinating disorder of the central nervous system, primarily affecting children between 3 and 7 years of age. It typically occurs 1–3 weeks after a viral, bacterial, or post-vaccination infection. Clinically, it presents with multifocal neurological deficits and encephalopathy, which may include altered consciousness, seizures, or cognitive disturbances. MRI shows widespread demyelinating lesions, mainly in the subcortical white matter. Laboratory findings may include elevated CRP, ESR, leukocytosis, and CSF pleocytosis. Treatment involves high-dose intravenous corticosteroids, with intravenous immunoglobulin or plasma exchange used in severe or refractory cases. Though usually monophasic, up to 25% of patients may experience relapses. Some children may require ICU care and early rehabilitation to address cognitive, motor, or speech deficits, highlighting the importance of timely diagnosis and management.